CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹7,123 Cr | ₹6,291 Cr | ₹4,990 Cr | ₹4,512 Cr | ₹4,249 Cr |
What is the latest Operating Profit of CIPLA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹7,123 Cr |
| Mar2025 | ₹6,291 Cr |
| Mar2024 | ₹4,990 Cr |
| Mar2023 | ₹4,512 Cr |
| Mar2022 | ₹4,249 Cr |
How is Operating Profit of CIPLA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,123 Cr | 13.22 | |
| Mar2025 | ₹6,291 Cr | 26.07 | |
| Mar2024 | ₹4,990 Cr | 10.60 | |
| Mar2023 | ₹4,512 Cr | 6.20 | |
| Mar2022 | ₹4,249 Cr | - | |
Compare Operating Profit of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹114,721.8 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| MANKIND PHARMA | ₹109,040.0 Cr | 0.2% | 17.2% | 15.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.7% |
6.7% |
-9.4% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses